Slavisa M Djuricic

Prof. Slavisa M Djuricic

Department of Clinical Pathology, Mother and Child Health Care Institute of Serbia “Dr. Vukan Cupic,“ Belgrade, Serbia; Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
KPKvetoslava Peckova
Kvetoslava Peckova
TVTomas Vanecek
Tomas Vanecek
PMPetr Martinek
Petr Martinek
DSDominic Spagnolo
Dominic Spagnolo
NKNaoto Kuroda
Naoto Kuroda
Ondrej HesOndrej Hes
Ondrej Hes

1 June 2010 in Parasitology International
Verified
Journal Article
Closed access
SDSlavisa M Djuricic
Slavisa M Djuricic
SGSlobodan Grebeldinger
Slobodan Grebeldinger
DKDejan I. Kafka
Dejan I. Kafka
IDIgor Djan
Igor Djan
MVMiroslav Vukadin
Miroslav Vukadin
ZVZorica Vasiljević
Zorica Vasiljević

30 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Emir BegagićEmir Begagić
Emir Begagić
HBHakija Bečulić
Hakija Bečulić
ADAmina Džidić-Krivić
Amina Džidić-Krivić
SVSamra Kadić Vukas
Samra Kadić Vukas
SHSemir Hadžić
Semir Hadžić
Mirza PojskicMirza Pojskic
Mirza Pojskic
Background: The study aims to investigate the role of hypoxia-inducible factors (HIFs) in the development, progression, and therapeutic potential of glioblastomas. Methodology: The study, following PRISMA guidelines, systematically examined hypoxia and HIFs in glioblastoma using MEDLINE (PubMed), Web of Science, and Scopus. A total of 104 relevant studies underwent data extraction. Results: Among the 104 studies, global contributions were diverse, with China leading at 23.1%. The most productive year was 2019, accounting for 11.5%. Hypoxia-inducible factor 1 alpha (HIF1α) was frequently studied, followed by hypoxia-inducible factor 2 alpha (HIF2α), osteopontin, and cavolin-1. Commonly associated factors and pathways include glucose transporter 1 (GLUT1) and glucose transporter 3 (GLUT3) receptors, vascular endothelial growth factor (VEGF), phosphoinositide 3-kinase (PI3K)-Akt-mechanistic target of rapamycin (mTOR) pathway, and reactive oxygen species (ROS). HIF expression correlates with various glioblastoma hallmarks, including progression, survival, neovascularization, glucose metabolism, migration, and invasion. Conclusion: Overcoming challenges such as treatment resistance and the absence of biomarkers is critical for the effective integration of HIF-related therapies into the treatment of glioblastoma with the aim of optimizing patient outcomes.

24 November 2008 in BMC Ear, Nose and Throat Disorders
Verified
Journal Article
Open access
PDF file
Semir VranicSemir Vranic
Semir Vranic
SCSamuel K Caughron
Samuel K Caughron
SDSlavisa M Djuricic
Slavisa M Djuricic
NBNurija Bilalovic
Nurija Bilalovic
SZSadiq Zaman
Sadiq Zaman
ZGZoran Gatalica
Zoran Gatalica
Germ-cell tumors (GCT) are a histologically and biologically diverse group of neoplasms which primarily occur in the gonads but also develop at different extragonadal sites in the midline of the body. The head and neck region including the upper respiratory tract is a very rare location for such tumors in both children and adults, which can cause diagnostic and therapeutic difficulties.

1 January 2006 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
ZSZ.B. Stankovic
Z.B. Stankovic
MDM.K. Djukic
M.K. Djukic
DSD. Savic
D. Savic
BLB.J. Lukac
B.J. Lukac
SDSlavisa M Djuricic
Slavisa M Djuricic
DZD. Zdravkovic
D. Zdravkovic
To investigate the importance of morphological scoring systems in differentiation of ovarian tumors in childhood. Morphological assessment using DePriest's index was performed for all patients with histopathological confirmation of ovarian tumor, with evaluation of tumor markers, from January 1997. Fifty-three girls (age range 13 months to 19 years) were surgically treated for 59 ovarian tumors, including six bilateral. All lesions with cystic appearance on ultrasonography were benign, 23 of 35 semisolid, and four of ten solid tumors were also benign. Stage of malignant disease was as follows: stage I, ten; stage II, two; stage III, six. Sensitivity, positive predictive value and accuracy by DePriest's and Ueland's indexes for benign tumors (score <7) were: 0.88, 0.79; 0.89; and 0.94, 0.84; 0.93; respectively. Elevated levels of tumor markers were observed in 17 patients, including four patients with endocrine manifestations. In 24 patients ovaries were successfully preserved, including two patients with foci of immature teratoma in a dermoid cyst. Ultrasonographic assessment with morphological analysis recommended by DePriest and Ueland is a very useful procedure for differentiating benign from malignant ovarian tumors in children. Tumor markers and endocrinological investigation are also useful for preoperative evaluation.

1 November 2014 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
NBNinoslav Begovic
Ninoslav Begovic
RSRadoje Simic
Radoje Simic
AVAleksandar Miladin Vlahovic
Aleksandar Miladin Vlahovic
DKDjordje Kravljanac
Djordje Kravljanac
SDSlavisa M Djuricic
Slavisa M Djuricic
TMTanja Mijovic
Tanja Mijovic